Summary

57.49 -0.35(-0.60%)05/10/2024
Corteva Inc (CTVA)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
2.086.280.026.4016.74-0.100.00107.52


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close57.53
Open56.66
High57.89
Low56.66
Volume4,257,670
Change1.17
Change %2.08
Avg Volume (20 Days)2,596,332
Volume/Avg Volume (20 Days) Ratio1.64
52 Week Range43.22 - 59.04
Price vs 52 Week High-2.56%
Price vs 52 Week Low33.11%
Range1.54
Gap Up/Down-1.13
Fundamentals
Market Capitalization (Mln)40,062
EBIDTA2,155,000,064
PE Ratio21.0309
PEG Ratio1.0705
WallStreet Target Price53.16
Book Value33.8780
Earnings Per Share2.2020
EPS Estimate Current Quarter-0.3100
EPS Estimate Next Quarter0.1600
EPS Estimate Current Year2.1400
EPS Estimate Next Year2.6000
Diluted EPS (TTM)2.2020
Revenues
Profit Marging0.1067
Operating Marging (TTM)0.0598
Return on asset (TTM)0.0139
Return on equity (TTM)0.0716
Revenue TTM15,383,000,064
Revenue per share TTM20.7840
Quarterly Revenue Growth (YOY)0.2730
Quarterly Earnings Growth (YOY)0.2960
Gross Profit (TTM)5,710,000,000
Dividends
Dividend Share0.5400
Dividend Yield0.0116
Valuations
Trailing PE21.0309
Forward PE18.7266
Price Sales (TTM)0.0000
Price Book (MRQ)1.4130
Revenue Enterprise Value 2.2460
EBITDA Enterprise Value10.4759
Shares
Shares Outstanding728,908,992
Shares Float727,983,286
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)0.11
Institutions (%)80.71


05/10 10:05 EST - Zacks Investment Research
4 Agriculture Operations Stocks to Watch Amid Elevated Costs
The Agriculture - Operations industry participants are witnessing higher costs due to fluctuating commodity prices, rising input costs and trade uncertainties. Innovations and improved consumer demand are likely to aid companies like CTVA, ADM, ALCO and AGRO.
05/02 13:16 EST - Seeking Alpha
Corteva, Inc. (CTVA) Q1 2024 Earnings Call Transcript
Corteva, Inc. (NYSE:CTVA ) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Kim Booth - Vice President, Investor Relations Chuck Magro - Chief Executive Officer Dave Anderson - Executive Vice President & Chief Financial Officer Tim Glenn - Executive Vice President, Seed Business Unit Robert King - Executive Vice President, Crop Protection Unit Conference Call Participants Vincent Andrews - Morgan Stanley Joel Jackson - BMO Capital Markets Kevin McCarthy - Vertical Research Frank Mitsch - Fermium Research Chris Parkinson - Wolfe Research Adam Samuelson - Goldman Sachs Ryan Weis - KeyBanc Capital Markets Arun Viswanathan - RBC Capital Markets Operator Thank you for standing by. My name is Mark and I will be your conference operator today.
05/01 20:01 EST - Zacks Investment Research
Compared to Estimates, Corteva, Inc. (CTVA) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Corteva, Inc. (CTVA) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
04/26 10:21 EST - Zacks Investment Research
Insights Into Corteva, Inc. (CTVA) Q1: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Corteva, Inc. (CTVA) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
04/26 10:10 EST - MarketBeat
3 Stocks Leading the U.S. Agriculture Comeback
Every cycle in the economy brings a different set of opportunities for investors. These are weighted as a balance between risk and potential reward.
04/12 15:50 EST - Bloomberg Markets and Finance
Ciena, Corteva, VF Corp | Top Calls
Top calls today are Ciena, Corteva and VF Corp.
04/08 17:00 EST - InvestorPlace
3 Agriculture Stocks to Buy for Multibagger Returns
Choosing agriculture stocks to buy will be challenging in the coming decades. The global population is expected to increase to 10 billion by 2050.
04/04 10:31 EST - Zacks Investment Research
Wall Street Bulls Look Optimistic About Corteva, Inc. (CTVA): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
04/02 14:40 EST - Seeking Alpha
Corteva's Strategic Ascend Post DowDuPont Split: Bridging Valuation Gaps
Corteva has outperformed the S&P 500 in the past five years, showcasing the benefits of the 2019 reorganization strategy. Despite its achievements, Corteva's market valuation still lags behind peers like Monsanto prior to their privatization, indicating potential for investor gains. Corteva's robust IP portfolio and strategic acquisitions, including the recent purchase of Stoller, underline its commitment to sustainable agricultural solutions.
03/11 15:07 EST - InvestorPlace
Earnings Crushers: Unveiling Q4's 3 Top Stock Superstars
As of March 1, virtually all S&P 500 companies had already reported earnings. Approximately 73% beat the earnings estimates, leaving investors with plenty of top stock superstars to choose from that blew through Wall Street's expectations.
02/16 10:35 EST - Zacks Investment Research
3 Agriculture Operations Stocks on the Radar as Inflation Hits Profits
The Agriculture - Operations industry participants have been impacted by commodity price inflation, reduced export projections and higher costs. Companies like CTVA, DOLE and ALCO stand to gain on solid product portfolios and innovation plans.
01/31 20:01 EST - Zacks Investment Research
Corteva, Inc. (CTVA) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
01/26 10:21 EST - Zacks Investment Research
Unveiling Corteva, Inc. (CTVA) Q4 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Corteva, Inc. (CTVA) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
01/19 12:41 EST - Zacks Investment Research
DOLE or CTVA: Which Is the Better Value Stock Right Now?
Investors interested in Agriculture - Operations stocks are likely familiar with Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?
01/17 15:59 EST - InvestorPlace
The 3 Best Agriculture Stocks to Buy in January 2024
The agricultural commodities sector was one of the hardest hit in recent years, thanks to the Russian invasion of Ukraine. Russia and Ukraine, the two largest wheat exporters, and their conflict disrupted the global food supply chain.
01/17 09:26 EST - InvestorPlace
7 Steadfast Stocks That Are Unaffected by Interest Rate Changes
Investors have been preoccupied with interest rates over the past year. The Federal Reserve raised interest rates at its fastest rate in many years.
01/10 13:17 EST - Seeking Alpha
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
01/03 12:47 EST - Zacks Investment Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Investors interested in stocks from the Agriculture - Operations sector have probably already heard of Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?
12/27 23:21 EST - InvestorPlace
Agriculture Advancements: 3 Stocks Cultivating Growth in Agri-Tech
These three agri-tech stocks will be boosted by the field's rapid growth.
12/16 07:12 EST - Finbold
US Politician makes suspicious health stock purchase
In a recent disclosure, United States Representative for Michigan's 6th congressional district Debbie Dingell has come under scrutiny for her stock purchase in Medtronic (NYSE: MDT), a prominent medical devices company.